Garcinia gummi-gutta's Effect on Polycystic Ovary Syndrome-Induced in Rats and Its Anti-Obesity Properties
Abstract
This study evaluated the effects of Garcinia gummi-gutta (L.) N.Robson (GG) on polycystic ovary syndrome (PCO)-induced in rats and its anti-obesity properties. Fifteen Wistar rats were divided into three groups: control, 10 mg/kg Aqueous Extract of Garcinia gummi-gutta (AEGG), and 20 mg/kg AEGG. PCO was induced using Letrozole-oestradiol, confirmed by vaginal smear tests and weight gain. AEGG was screened for phenol (125.66±1.07 µg/mL) and flavonoid (102.66 ± 0.38 µg/ml) content, with its highest concentrations at 20 mg/mL. Pancreatic lipase inhibition showed AEGG’s anti-lipase effect (66.24%) at 100 μg/mL, compared to orlistat (98.7%) at 1 μg/ml. Rats received 20 mg/kg of AEGG demonstrated the highest significant reduction in body weight (203.8 g ±1.45 SD) and serum luteinizing hormone (LH) levels (1.24 mIU/mL) compared to the 10 mg/kg group and control group. Anatomical examination showed a normal uterus and reduced ovarian cysts in both AEGG-treated groups compared to the control. AEGG, particularly at 20 mg/kg, significantly reduced body weight, LH levels, and reproductive anatomy in PCO-induced rats, while demonstrating potential anti-obesity effects despite lower lipolytic activity compared to orlistat. The study suggests that AEGG at 20 mg/kg offers benefits in managing PCO and preventing obesity.
Hoyt KL, Schmidt MC. Polycystic ovary (Stein-Leventhal) syndrome: etiology, complications, and treatment. Clin Lab Sci 2004;17:155-163.
Umland EM. Menstruation related disorders. Pharmacotherapy: A Pathophysiologic Approach. 8th ed. McGraw-Hill. 2011; p 1393.
McFarland C. Treating polycystic ovary syndrome and infertility. Am J Matern Child Nurs 2012;37:116-121.
Norman RJ, Dewailly D, Legro RS, Hickey TE. Polycystic ovary syndrome. The Lancet 2007;370:685-697.
Singh KB. Persistent estrus rat models of polycystic ovary disease: An update. Fertil Steril 2005;84:1228-1234.
Goldman JM, Murr AS, Cooper RL. The rodent estrous cycle: Characterization of vaginal cytology and its utility in toxicological studies. Birth Defects Res B Dev Reprod Toxicol 2007;80:84-97.
Mannerås L, Cajander S, Holmäng A, Seleskovic Z, Lystig T, et al. A new rat model exhibiting both ovarian and metabolic characteristics of polycystic ovary syndrome. Endocrinology 2007;148:3781-3791.
Urbanek M. The genetics of the polycystic ovary syndrome. Nat Clin Pract Endocrinol Metab 2007;3:103-111.
Akre S, Sharma K, Chakole S, Wanjari MB. Recent advances in the management of polycystic ovary syndrome: a review article. Cureus. 2022;14:e27689.
Jiménez-Osorio AS, Monroy A, Alavez S. Curcumin and insulin resistance—Molecular targets and clinical evidences. BioFactors 2016;42:561-580.
Baby B, Rani S, KR, Rasheed SP, AK A. Polycystic ovarian syndrome: Therapeutic potential of herbal remedies—A review. Int J Herb Med 2016;91:91-96.
Rooney S, Pendry B. Phytotherapy for Polycystic Ovarian Syndrome: A review of the literature and evaluation of practitioners’ experiences. J Herb Med 2014;4:159-171.
Swaroop A, Jaipuriar AS, Gupta SK, Bagchi M, Kumar P, et al. Efficacy of a novel fenugreek seed extract (Trigonella foenum-graecum, furocystTM) in polycystic ovary syndrome (PCOS). Int J Med Sci 2015;12:825-831.
Rana S, Hussain L, Saleem U, Asif M, Lodhi AH, et al. Dose dependent effects of aqueous extract of garcinia cambogia desr. against letrozole induced polycystic ovarian syndrome in female adult rats with possible mechanisms exploration. Dose-Response. 2023;21.
Kavita MS. Processing and preservation qualities of value added products based on Garcinia cambogia [Malabar Tamarind]. IOSR J Environ Sci Toxicol Food Technol 2014;8:1-9.
Subhashini N, Nagarajan G, Kaviman S. In vitro antioxidant and anticholinesterase activities of Garcinia cambogia. Int J Pharm Pharm Sci. 2011;3:129-132.
Iinuma M, Ito T, Miyake R, Tosa H, Tanaka T, et al. A xanthone from Garcinia cambogia. Phytochemistry 1998;47:1169-1170.
Masullo M, Bassarello C, Suzuki H, Pizza C, Piacente S. Polyisoprenylated benzophenones and an unusual polyisoprenylated tetracyclic xanthone from the fruits of Garcinia cambogia. J Agric Food Chem. 2008;56:5205-5210.
Masullo M, Bassarello C, Bifulco G, Piacente S. Polyisoprenylated benzophenone derivatives from the fruits of Garcinia cambogia and their absolute configuration by quantum chemical circular dichroism calculations. Tetrahedron 2010;66:139-145.
Lewis YS, Neelakantan S. (-)-Hydroxycitric acid-the principal acid in the fruits of Garcinia cambogia desr. Phytochemistry 1965;4:619-625.
Antony B, Varghese W, Elias M. Preparation and evaluation of hydroxy citric acid from Garcinia cambogia extract using RP-amide HPLC. Indian J Pharm Sci. 2004;66:208-211.
Kuriyan K. A note on the main constituents of the dried rind of the fruit of Garcinia cambogia. J Indian Chem Soc 1931;8:469.
Sreenivasan AVR. Chromatographic detection of the organic constituents of Gorikapuli (Garcinia cambogia Desr.) used in pickling fish. Curr Sci 1959;28:151-152.
Jena BS, Jayaprakasha GK, Singh RP, Sakariah KK. Chemistry and biochemistry of (-)-hydroxycitric acid from Garcinia. J Agric Food Chem 2002;50:10-22.
Mahapatra S, Mallik SB, Rao GV, Reddy GC, Row TNG. Garcinia lactone. Acta Crystallogr Sect E Struct Rep Online 2007;63:o3869.
Semwal RB, Semwal DK, Vermaak I, Viljoen A. A comprehensive scientific overview of Garcinia cambogia. Fitoterapia 2015;102:134-148.
Gupte P, Harke S, Deo V, Bhushan Shrikhande B, Mahajan M, et al. A clinical study to evaluate the efficacy of Herbal Formulation for Obesity (HFO-02) in overweight individuals. J Ayurveda Integr Med 2020;11:159-162.
Onakpoya I, Hung SK, Perry R, Wider B, Ernst E. The use of garcinia extract (hydroxycitric acid) as a weight loss supplement: A systematic review and meta-analysis of randomised clinical trials. J Obes. 2011;2011:509038.
Shi D, Vine DF. Animal models of polycystic ovary syndrome: A focused review of rodent models in relationship to clinical phenotypes and cardiometabolic risk. Fertil Steril 2012;98:185-193.
Sağsak E, Keskin M, Çetinkaya S, Erdeve ŞS, Aycan Z. The diagnostic value of free androgen index in obese adolescent females with idiopathic hirsutism and polycystic ovary syndrome. J Acad Res Med 2021;11.
Hardiman P, Pillay OS, Atiomo W. Polycystic ovary syndrome and endometrial carcinoma. Lancet 2003;361:1810-1812.
Van Loon LJC, Van Rooijen JJM, Niesen B, Verhagen H, Saris WHM, et al. Effects of acute (-)-hydroxycitrate supplementation on substrate metabolism at rest and during exercise in humans. Am J Clin Nutr 2000;72:1445-1450.
Kim JE, Jeon SM, Park K, Lee W, Jeong TS, et al. Does Glycine max leaves or Garcinia Cambogia promote weight-loss or lower plasma cholesterol in overweight individuals: A randomized control trial. Nutr J 2011;10:94.
Kriketos AD, Thompson HR, Greene H, Hill JO. (-)-Hydroxycitric acid does not affect energy expenditure and substrate oxidation in adult males in a post-absorptive state. Int J Obes Relat Metab Disord 1999;23:867-873.
Leray V, Dumon H, Martin L, Siliart B, Sergheraert R, et al. No effect of conjugated linoleic acid or Garcinia cambogia on fat-free mass, and energy expenditure in normal cats. J Nutr 2006;136:1982S-1984S.
Bhalodia N, Nariya P, Shukla V, Acharya R. In vitro antioxidant activity of hydro alcoholic extract from the fruit pulp of Cassia fistula Linn. AYU (An International Quarterly Journal of Research in Ayurveda). 2013;34:209-214.
Patel A, Patel A, Patel A, Patel NM. Estimation of flavonoid, polyphenolic content and in vitro antioxidant capacity of leaves of Tephrosia purpurea Linn. (Leguminosae). Int J Pharm Sci Res 2010;1:66-77.
Patel S, Jayvadan P, Patel RK. To study proximate analysis and biological evaluation of Triphala Guggulu formulation. Int J Pharm Tech Res 2012;4:1520-1526.
Kim YS, Lee YM, Kim H, Kim J, Jang DS, et al. Anti-obesity effect of Morus bombycis root extract: Anti-lipase activity and lipolytic effect. J Ethnopharmacol 2010;130:621-624.
Tamadon A, Hu W, Cui P, Ma T, Tong X, et al. How to choose the suitable animal model of polycystic ovary syndrome? Trad Med Modern Med 2018;01:95-113.
Atis A, Aydin Y, Ciftci F, Sakız D, Arslan A, et al. Hyperbaric oxygen increases atresia in normal and amp; steroid-induced PCO rat ovaries. Reprod Biol Endocrinol 2012;10:11.
Singh S, Pal N, Shubham S, Sarma DK, Verma V, et al. Polycystic ovary syndrome: etiology, current management, and future therapeutics. J Clin Med 2023;12:1454.
Yun JW. Possible anti-obesity therapeutics from nature - A review. Phytochemistry 2010;71:011.
Ghasemian F, Esmaeilnezhad S. Metformin, clomiphene citrate and flutamide effects on oocyte ultrastructure status and quality in PCOS mouse model. Reprod Biomed Online 2022;45:191-201.
Tan BK, Heutling D, Chen J, Farhatullah S, Adya R, et al. Metformin decreases the adipokine vaspin in overweight women with polycystic ovary syndrome concomitant with improvement in insulin sensitivity and a decrease in insulin resistance. Diabetes 2008;57:1501-1507.
Heck AM, Yanovski JA, Calis KA. Orlistat, a new lipase inhibitor for the management of obesity. Pharmacotherapy 2000;20:270-279.
Simard M, Brawer JR, Farookhi R. An intractable, ovary-independent impairment in hypothalamo-pituitary function in the estradiol-valerate-induced polycystic ovarian condition in the rat. Biol Reprod 1987;36:1229-1237.
| Issue | Vol 10, No 1, 2025 -In Press- | |
| Section | Research Article(s) | |
| Keywords | ||
| Garcinia cambogia Polycystic ovarian disease Obesity Luteinizing hormone Uterus Ovary Pancreatic lipase | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
